Selected data models

You must log in to select data models for download or further analysis.

19 Search results.
Relevance Rating New first Old first

Eligibility Osteoarthritis NCT00662896

- 8/5/18 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00662896

Eligibility Localized Primary Osteoarthritis of Hip NCT01765296

- 7/2/20 - 1 form, 1 itemgroup, 32 items, 1 language
Itemgroup: Criteria
Phase III Study of CG100649 in Osteoarthritis Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01765296

Eligibility Hip Osteoarthritis NCT01920152

- 6/7/20 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Clinical Trial Evaluating Platelet Rich Plasma Versus Hyaluronic-Acid in the Short-term Treatment of Symptomatic OA (Osteoarthritis) of the Hip; ODM derived from: https://clinicaltrials.gov/show/NCT01920152

Eligibility Hip Osteoarthritis NCT02086474

- 2/27/20 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Daily Activity and Gait Analysis After Viscosupplement Injection Among Hip Osteoarthritis Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02086474

Eligibility Hip Osteoarthritis NCT01492257

- 1/2/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Shared Decision Making in Patients With Osteoarthritis of the Hip and Knee; ODM derived from: https://clinicaltrials.gov/show/NCT01492257

Eligibility Osteoarthritis, Hip NCT01039337

- 8/11/18 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Conservative Treatment for Hip Osteoarthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01039337

Eligibility Osteoarthritis of the Hip NCT00449228

- 8/9/18 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy of Preoperative Education and Mini-invasive Surgery for Total Hip Replacement; ODM derived from: https://clinicaltrials.gov/show/NCT00449228

Eligibility Osteoarthritis NCT01728246

- 8/9/18 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
An Efficacy, Safety and Effects on Quality of Life of Tramadol/Paracetamol as Add-on Therapy in Chronic Osteoarthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01728246

Eligibility Osteoarthritis NCT00864097

- 8/7/18 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip; ODM derived from: https://clinicaltrials.gov/show/NCT00864097

Eligibility Osteoarthritis NCT00662610

- 8/4/18 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure; ODM derived from: https://clinicaltrials.gov/show/NCT00662610

Eligibility Osteoarthritis NCT00541489

- 8/3/18 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip; ODM derived from: https://clinicaltrials.gov/show/NCT00541489

Index of severity for osteoarthrosis of the hip (ISOA Hip)

- 4/27/18 - 1 form, 5 itemgroups, 13 items, 1 language
Itemgroups: Pain or discomfort, Walking, Activities of Daily Living, Sexual Activity, Total score
Both the index of severity for osteoarthrosis (OA) of the hip and the index of severity for OA of the knee "are believed to be of value in therapeutic trials in OA of weight-bearing joints. They also provide a measurable appraisal of patient status at different stages of OA, provide information on the long-term natural disease course, benefit from a “chondroprotective” drug, and establish a scale of disability to direct orthopedic intervention such as arthroplasty or tibia osteotomy." (Lequesne, 1991; p. 49) References: Lequesne, M. G., Mery, C., Samson, M., & Gerard, P. (1987). Indexes of severity for osteoarthritis of the hip and knee: validation–value in comparison with other assessment tests. Scandinavian Journal of Rheumatology, 16(sup65), 85-89. Lequesne, M. (1991, June). Indices of severity and disease activity for osteoarthritis. In Seminars in arthritis and rheumatism (Vol. 20, No. 6, pp. 48-54). WB Saunders.

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial